Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134747) titled 'Study of the blood-interstitial fluid glucose gradient for early warning and dynamic classification of skin failure in patients with sepsis' on Oct. 20.

Study Type: Observational study

Study Design: Cohort study

Primary Sponsor: Drum Tower Hospital

Condition: Sepsis Acute skin failure

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2027-01-01

Target Sample Size: Exposure group:500;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=341726

Disclaimer: Curated by HT Syndication....